Atlas Trials

Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

Clinical trial NCT04943757 · COMPLETED

Trial details

NCT number
NCT04943757
Sponsor
St. Petersburg State Pavlov Medical University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloid Leukemia, AcuteChronic Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm
Start date
2021-01-21
Primary completion
2024-05-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.